CHEN Rong. Interpretation on the 2023 Chinese Menopause Symptom Management and Menopausal Hormone Therapy Guidelines[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(3): 514-519. DOI: 10.12290/xhyxzz.2023-0190
Citation: CHEN Rong. Interpretation on the 2023 Chinese Menopause Symptom Management and Menopausal Hormone Therapy Guidelines[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(3): 514-519. DOI: 10.12290/xhyxzz.2023-0190

Interpretation on the 2023 Chinese Menopause Symptom Management and Menopausal Hormone Therapy Guidelines

Funds: 

National High Level Hospital Clinical Research Funding 2022-PUMCH-B-123

More Information
  • Author Bio:

    CHEN Rong, E-mail: chenrongpumch@163.com

  • Received Date: April 11, 2023
  • Accepted Date: April 23, 2023
  • Available Online: April 26, 2023
  • Issue Publish Date: May 29, 2023
  • The essence of menopause is ovarian failure, which has a significant impact on women's health. The goal of menopausal management is to relieve menopause-related symptoms, and hopefully, prevent chronic diseases in old age. Based on comprehensive lifestyle management, various health care measures including menopausal hormone therapy have been carried out under the guidance of professional medical practitioners so as to improve and enhance the quality of life of middle-aged and elderly women. The 2023 Chinese Menopause Symptom Management and Menopausal Hormone Therapy Guidelines was officially published in January 2023, and this article interprets the core points of the guidelines, especially the main updates, in order to better guide clinical practice.
  • [1]
    Bai R, Liu Y, Zhang L, et al. Projections of future life expectancy in China up to 2035: a modelling study[J]. Lance Public Health, 2023: S2468-2667(22)00338-3.
    [2]
    中华医学会妇产科学分会绝经学组. 中国绝经管理与绝经激素治疗指南2023版[J]. 中华妇产科杂志, 2023, 58: 4-21. https://www.cnki.com.cn/Article/CJFDTOTAL-XHYX201806007.htm
    [3]
    中华医学会妇产科学分会绝经学组. 中国绝经管理与绝经激素治疗指南(2018)[J]. 协和医学杂志, 2018, 9: 512-525. DOI: 10.3969/j.issn.1674-9081.2018.06.007
    [4]
    Collaborative Group on Hormonal Factors in Breast Cancer. Type and timing of menopausal hormone therapy and breast cancer risk: individual articipant meta-analysis of the worldwide epidemiological evidence[J]. Lancet, 2019, 394: 1159-1168. DOI: 10.1016/S0140-6736(19)31709-X
    [5]
    Vinogradova Y, Coupland C, Hippisley-Cox J. Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases[J]. BMJ, 2020, 371: m3873. http://www.xueshufan.com/publication/3097702496
    [6]
    Chlebowski RT, Anderson GL, Aragaki AK, et al. Association of Menopausal Hormone Therapy with Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials[J]. JAMA, 2020, 324: 369-380. DOI: 10.1001/jama.2020.9482
    [7]
    The 2022 hormone therapy position statement of The North American Menopause Society[J]. Menopause, 2022, 29: 767-794.
    [8]
    Academic Committee of the Korean Society of Menopause, Lee SR, Cho MK, et al. The 2020 Menopausal Hormone Therapy Guidelines[J]. J Menopausal Med, 2020, 26: 69-98. DOI: 10.6118/jmm.20000
    [9]
    Harlow SD, Gass M, Hall JE, et al. STRAW+10 Collaborative Group. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging[J]. Menopause, 2012, 19: 387-395. DOI: 10.1097/gme.0b013e31824d8f40
    [10]
    Li J, Luo M, Tang R, et al. Vasomotor symptoms in aging Chinese women: findings from a prospective cohort study[J]. Climacteric, 2020, 23: 46-52. DOI: 10.1080/13697137.2019.1628734
    [11]
    Saccardi C, Spagnol G, Bonaldo G, et al. New Light on Endometrial Thickness as a Risk Factor of Cancer: What Do Clinicians Need to Know?[J]. Cancer Manag Res, 2022, 14: 1331-1340. DOI: 10.2147/CMAR.S294074
    [12]
    中华医学会妇产科学分会绝经学组. 围绝经期异常子宫出血诊断和治疗专家共识[J]. 中华妇产科杂志, 2018, 53: 396-401 DOI: 10.3760/cma.j.issn.0529-567x.2018.06.007
    [13]
    绝经生殖泌尿综合征临床诊疗专家共识专家组. 绝经生殖泌尿综合征临床诊疗专家共识[J]. 中华妇产科杂志, 2020, 55: 659-666.
    [14]
    中华医学会计划生育学分会. 40岁及以上女性避孕指导专家共识[J]. 中华妇产科杂志, 2020, 55: 239-245.
  • Related Articles

    [1]TIAN Zhuang, ZHANG Shuyang. Interpretation on Chinese Guidelines for the Diagnosis and Treatment of Heart Failure 2024[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(4): 801-806. DOI: 10.12290/xhyxzz.2024-0292
    [2]TIAN Xinping, ZHAO Jiuliang, LI Mengtao, SONG Yijun, LIU Juntao, ZENG Xiaofeng. Interpretation on the 2022 Chinese Guideline for the Management of Pregnancy and Reproduction in Patients with Systemic Lupus Erythematous[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(3): 504-513. DOI: 10.12290/xhyxzz.2023-0119
    [3]LIANG Yun, WU Wenming, NIE Yongzhan, CHEN Jie. Interpretation on the Chinese Guideline for Diagnosis and Treatment of Neuroendocrine Neoplasms from The China Anti-Cancer Association(2022)[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(1): 94-100. DOI: 10.12290/xhyxzz.2022-0607
    [4]WU Juelun, SHEN Le. Evaluation, Preparation, Decision, and Oxygenation: Interpretation on 2022 American Society of Anesthesiologists Practice Guidelines for Management of the Difficult Airway[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(3): 421-426. DOI: 10.12290/xhyxzz.2022-0075
    [5]WANG Lin, SONG Hongmei. Interpretation on Chinese Guidelines for the Diagnosis and Treatment of Childhood-onset Systemic Lupus Erythematosus[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(3): 412-420. DOI: 10.12290/xhyxzz.2022-0018
    [6]Ying XU, Ya-li XU, Zhe WANG, Yan LIN, Chang-jun WANG, Qiang SUN. Menopausal Hormone Therapy Increases the Risk of Breast Cancer:Interpretation on an Article Published in the Lancet Sep. 2019[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(5): 621-625. DOI: 10.3969/j.issn.1674-9081.2020.05.020
    [7]Yun WANG, Ze-hao WU, Yu-guang HUANG. Standardization and Normalization: Interpretation on Guidelines for Perioperative Care in Esophagectomy: Enhanced Recovery after Surgery Society Recommendations[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(6): 575-581. DOI: 10.3969/j.issn.1674-9081.2019.06.005
    [8]Zi-jia LIU, Hui-zhen HUANG, Yu-guang HUANG. From Enhanced Recovery after Surgery to Day-case Surgery: Interpretation on Guidelines for Day-case Surgery 2019: Guidelines from the Association of Anaesthetists and the British Association of Day Surgery[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(6): 570-574. DOI: 10.3969/j.issn.1674-9081.2019.06.004
    [9]Xiao-dong TIAN, Yin-mo YANG. Concept Renewal Leads to Behavior Progress: Interpretation on the Surgical Part of Consensus on ERAS and Guidelines for Pathway Management in China (2018)[J]. Medical Journal of Peking Union Medical College Hospital, 2018, 9(6): 485-489. DOI: 10.3969/j.issn.1674-9081.2018.06.002
    [10]Tian-long WANG, Yu-guang HUANG. Campaigning for the Transformation from Anesthesiology to Perioperative Medicine: Interpretation on the Anesthesia Part of Consensus on ERAS and Guidelines for the Pathway Management in China (2018)[J]. Medical Journal of Peking Union Medical College Hospital, 2018, 9(6): 481-484. DOI: 10.3969/j.issn.1674-9081.2018.06.001
  • Cited by

    Periodical cited type(28)

    1. 叶晨书,沈明霞,马倩雯. 基于“冲脉隶于阳明”论治月经病. 浙江中西医结合杂志. 2025(01): 77-79 .
    2. 唐宇,孙雪梅,张莉莉,秦琪,王艳萍. 中药治疗绝经综合征失眠作用机制研究进展. 中国老年学杂志. 2025(03): 747-751 .
    3. 罗丽敏,吴艳晴,蒋凌,罗顺祥,徐尚华. 不同年龄、性别和高血压级别的中老年高血压患者心肌做功超声心动图指标的差异. 中华高血压杂志(中英文). 2025(01): 59-66 .
    4. 应慧珍,吉丽,孔文娟,王媛,陈晓霞,胡彩虹,傅海英,卢园园,车秀丽. 磐安县绝经女性绝经综合征调查. 预防医学. 2025(03): 312-315 .
    5. 李玮琳,郭婷,秦莹莹. 绝经年龄影响因素研究进展. 中国科学:生命科学. 2024(01): 136-146 .
    6. 魏辰,王子贤,李淑璠,王芃,贾舒祺,田英. 镜像疗法对脑卒中患者上肢运动功能和日常生活活动能力影响的Meta分析. 中国康复理论与实践. 2024(03): 281-291 .
    7. 郭建新,高爽,韩健,刘强,王贤华. 绝经与性功能障碍. 中国计划生育和妇产科. 2024(03): 21-22+28 .
    8. 周琦,邹冬玲,张师前,王雅卓,龙行涛. 妇科恶性肿瘤激素补充治疗中国专家共识(2024年版). 中国实用妇科与产科杂志. 2024(03): 305-311 .
    9. 马菱蔚,冯源原,孙鑫萌,吴志勇,张炜,夏和霞. 性激素在绝经激素治疗中的应用及展望. 世界临床药物. 2024(02): 107-111 .
    10. 王存利,王红霞,庞鑫,孔令慧. 绝经期配偶支持问卷的汉化及信效度检验. 护理学杂志. 2024(07): 48-52 .
    11. 汪先花,兰锶鍚,蒋庆丽,唐继鸿,何梅. 中国围绝经期女性绝经激素治疗依从性及影响因素的Meta分析. 现代医学. 2024(03): 427-434 .
    12. 刘娜,刘霞,李汉强,张奕奕. 中医外治疗法治疗更年期综合征的研究进展. 中国民间疗法. 2024(11): 125-129 .
    13. 毕富玺,闫颖,马静. 基于脑肠轴理论探讨针刺治疗肾阴虚型绝经综合征伴焦虑障碍的临床疗效. 天津中医药. 2024(06): 754-758 .
    14. 郑学璇,梁叶丽,晁晶. 量化自我管理模式对围绝经期女性生活质量影响的研究. 中国现代医药杂志. 2024(06): 44-47 .
    15. 康悦,段应龙,秦宁,董小倩,李莹,谢建飞. 离退休中老年人睡眠障碍状况调查及其影响因素. 中国医师杂志. 2024(05): 778-781 .
    16. 张玉菡,伍琼芳,夏雷震,苏琼. 雌激素的2种给药途径对高龄女性冻融胚胎移植临床结局的影响. 实用临床医学. 2024(03): 39-41+132 .
    17. 郑琼霞,李玲. 基于结构方程模型的围绝经期女性睡眠质量影响路径分析. 心理月刊. 2024(13): 37-40+80 .
    18. 李佳慧,林楚然,闫瑞忠,申合毅,范学敏,张权. 淫羊藿、当归及其配伍用药对绝经后骨质疏松症大鼠TGF-β1/Smads信号通路的影响. 中医药导报. 2024(08): 47-52 .
    19. 朱丽君,徐莲薇,李克倩,李盛楠. 围绝经期抑郁症发病机制及中医药防治研究进展. 中国实验方剂学杂志. 2024(21): 252-261 .
    20. 李盼盼,崔海洋,肖岑宇,黄群群,高晓黎. 复方结合雌激素黄体酮阴道用乳膏的乳化剂筛选与体外释放研究. 新疆医科大学学报. 2024(09): 1274-1280 .
    21. 刘舒悦,王素美. 基于数据挖掘探讨名中医治疗更年期综合征寒热错杂证用药规律. 光明中医. 2024(19): 3832-3836 .
    22. 王东阳,林欣潮,李若尘,杨巧慧. 不同绝经阶段肌力水平与骨密度和骨代谢指标之间的相关性. 基础医学与临床. 2024(11): 1557-1562 .
    23. 朱艳艳,罗彩凤,卞泽坤,尚彬,吕妃,孙炜怡. 基于网络分析的社区女性围绝经期综合征核心症状及相关因素研究. 护理学杂志. 2024(21): 99-104 .
    24. 黄莉,谌尧垚,潘永芳,赵家卉,彭琪媛,纪桂芬. 补肾壮骨颗粒对绝经后骨质疏松患者血清VEGF、骨形成指标及骨密度影响的临床观察. 医药前沿. 2024(14): 128-130+134 .
    25. 王舒心,侯梦卉,李莹,张清钥,楚欣莹,马静. 滋水清肝饮治疗围绝经期综合征潮热汗出的疗效:回顾性队列研究. 承德医学院学报. 2024(06): 483-487 .
    26. 张蕾,陈壹明,袁慧. 北京地区老年人群凝血酶-抗凝血酶复合物和纤溶酶-α2纤溶酶抑制剂复合物参考区间的研究. 国际检验医学杂志. 2024(23): 2844-2848 .
    27. 和彩玲,姜晓雪,王洁敏,张莹丽,尹虹. 司美格鲁肽联合药物治疗2型糖尿病合并围绝经期代谢综合征1例. 中华糖尿病杂志. 2024(Z1): 66-69 .
    28. 冯嘉楠,陶丽新,郭秀花,陈硕,康晓平. 围绝经期与代谢综合征的关联性研究. 中国医药导报. 2023(30): 104-107 .

    Other cited types(15)

Catalog

    Article Metrics

    Article views (3975) PDF downloads (3267) Cited by(43)
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return
    x Close Forever Close